MB02 clinical trials
A product of Bevacizumab; its studies count on that page too.
How each study uses MB02 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 26 Feb 2004 · AVASTIN · BLA 125085 (FDA, Drugs@FDA; as Bevacizumab)
- European Union
- 12 Jan 2005 · Avastin · EMEA/H/C/000582 (EMA; as Bevacizumab)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Related medicines
As reviewed, each with the page that says it.
- A biosimilar of Bevacizumab
Studies
Open first, then newest update. How each study uses MB02 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male VolunteersCompletedPhase 1mAbxience Research S.L.NCT04238663Written as MB02 (Bevacizumab Biosimilar)
- A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)CompletedPhase 3mAbxience Research S.L.NCT03296163Written as MB02 (Bevacizumab Biosimilar Drug)
- A Pharmacokinetic Study Comparing MB02 And EU Avastin® In Healthy Male VolunteersCompletedPhase 1mAbxience Research S.L.NCT04238650Written as MB02 (Bevacizumab Biosimilar)
- A Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male VolunteersCompletedPhase 1mAbxience Research S.L.NCT03293654Written as MB02